304 related articles for article (PubMed ID: 11651046)
1. Patient-funded research: paying the piper or protecting the patient?
Morreim EH
IRB; 1991; 13(3):1-6. PubMed ID: 11651046
[No Abstract] [Full Text] [Related]
2. In business to treat cancer.
Henig RM
N Y Times Mag; 1986 Nov; ():68, 70, 78, 80+. PubMed ID: 11647805
[No Abstract] [Full Text] [Related]
3. The case for per patient payments.
Lewis JP
IRB; 1988; 10(5):9. PubMed ID: 11650075
[No Abstract] [Full Text] [Related]
4. Policies and quality assurance in the pharmaceutical industry.
Shamoo AE
Account Res; 1991; 1(4):273-84. PubMed ID: 11651459
[No Abstract] [Full Text] [Related]
5. Playing roulette with experimental drugs.
Budiansky S
US News World Rep; 1987 Jul; 103(2):58-9. PubMed ID: 11658841
[No Abstract] [Full Text] [Related]
6. An overview of legal controls on human experimentation and the regulatory implications of taking Professor Katz seriously.
Goldner JA
St Louis Univ Law J; 1993; 38(1):63-134. PubMed ID: 11656325
[No Abstract] [Full Text] [Related]
7. An ethical framework for the practice of paying research subjects.
Ackerman TF
IRB; 1989; 11(4):1-4. PubMed ID: 11650243
[No Abstract] [Full Text] [Related]
8. Drug trials hide conflicts for doctors.
Eichenwald K; Kolata G
N Y Times Web; 1999 May; ():1, 34. PubMed ID: 11648114
[No Abstract] [Full Text] [Related]
9. Informed consent in human experimentation: bridging the gap between ethical thought and current practice.
Delgado R; Leskovac H
UCLA Law Rev; 1986 Oct; 34(1):67-130. PubMed ID: 11659049
[No Abstract] [Full Text] [Related]
10. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform.
Maatz CT
High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962
[No Abstract] [Full Text] [Related]
11. Human experimentation and human rights.
Katz J
St Louis Univ Law J; 1993; 38(1):7-54. PubMed ID: 11656326
[No Abstract] [Full Text] [Related]
12. May a human subject waive the right to be treated as a human subject?
Novick A
AIDS Public Policy J; 1990; 5(1):45-8. PubMed ID: 11650389
[No Abstract] [Full Text] [Related]
13. Dilemmas in paying for clinical research: the view from the IRB.
Lind SE
IRB; 1987; 9(2):1-5. PubMed ID: 11649900
[No Abstract] [Full Text] [Related]
14. Should informed consent include information on how research is funded?
Finkel MJ
IRB; 1991; 13(5):1-3. PubMed ID: 11651248
[No Abstract] [Full Text] [Related]
15. Considering experimentation and elusive truth: informed consent made difficult.
Brodeur D
Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
[No Abstract] [Full Text] [Related]
16. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
Kobasic DM
J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
[No Abstract] [Full Text] [Related]
17. The doctor's unproven belief and the subject's informed choice: another commentary.
Marquis D; Stephens R; Levine RJ
IRB; 1989; 11(3):8-11. PubMed ID: 11650208
[No Abstract] [Full Text] [Related]
18. Guinea pigs on the payroll: the ethics of paying research subjects.
Lemmens T; Elliott C
Account Res; 1999; 7(1):3-20. PubMed ID: 11657561
[No Abstract] [Full Text] [Related]
19. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials.
Annas GJ
Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162
[No Abstract] [Full Text] [Related]
20. Conflicts of interest: research and clinical care.
Morris JC
Alzheimer Dis Assoc Disord; 1994; 8(Suppl. 4):49-57. PubMed ID: 11657673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
